Gary Reubenson to Infant
This is a "connection" page, showing publications Gary Reubenson has written about Infant.
Connection Strength
0,511
-
Risk Factors for Severe COVID-19 Among Children and Adolescents Enrolled in Acute Respiratory Infection Sentinel Surveillance in South Africa, 2020-2022. Influenza Other Respir Viruses. 2024 May; 18(5):e13300.
Score: 0,038
-
International Pediatric COVID-19 Severity Over the Course of the Pandemic. JAMA Pediatr. 2023 10 01; 177(10):1073-1084.
Score: 0,036
-
Changing Epidemiology of COVID-19 in Children and Adolescents Over Four Successive Epidemic Waves in South Africa, 2020-2022. J Pediatric Infect Dis Soc. 2023 Apr 18; 12(3):128-134.
Score: 0,035
-
Bronchiolitis versus bronchopneumonia: navigating antibiotic use within the LRTI spectrum. S Afr Med J. 2023 03 20; 113(6):20-23.
Score: 0,035
-
Case-fatality and sequelae following acute bacterial meningitis in South Africa, 2016 through 2020. Int J Infect Dis. 2022 Sep; 122:1056-1066.
Score: 0,034
-
Trends in paediatric tuberculosis diagnoses in two South African hospitals early in the COVID-19 pandemic. S Afr Med J. 2020 11 02; 110(12):1149-1150.
Score: 0,030
-
Congenital Rubella Syndrome Surveillance in South Africa Using a Sentinel Site Approach: A Cross-sectional Study. Clin Infect Dis. 2019 05 02; 68(10):1658-1664.
Score: 0,027
-
Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003-2008. Pediatr Infect Dis J. 2019 04; 38(4):424-430.
Score: 0,027
-
Molecular Detection of Mycobacterium tuberculosis from Stools in Young Children by Use of a Novel Centrifugation-Free Processing Method. J Clin Microbiol. 2018 09; 56(9).
Score: 0,026
-
Risk factors for pertussis among hospitalized children in a high HIV prevalence setting, South Africa. Int J Infect Dis. 2018 Mar; 68:54-60.
Score: 0,025
-
Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network. J Acquir Immune Defic Syndr. 2017 Jun 01; 75(2):156-163.
Score: 0,023
-
Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
Score: 0,023
-
Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants. Vaccine. 2015 Nov 27; 33(48):6793-9.
Score: 0,021
-
Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants. Expert Rev Vaccines. 2015; 14(12):1651-60.
Score: 0,021
-
Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013. Clin Infect Dis. 2015 May 01; 60(9):1346-56.
Score: 0,020
-
Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J. 2015 Jan; 34(1):27-34.
Score: 0,020
-
Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study. Clin Infect Dis. 2014 Sep 15; 59(6):808-18.
Score: 0,019
-
Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices. J Pediatric Infect Dis Soc. 2015 Mar; 4(1):30-8.
Score: 0,019
-
Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children. Pediatr Infect Dis J. 2013 Aug; 32(8):851-5.
Score: 0,018
-
High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis. 2011 Jan 26; 11:28.
Score: 0,015